252 related articles for article (PubMed ID: 19703885)
1. Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging.
Bäuerle T; Hillengass J; Fechtner K; Zechmann CM; Grenacher L; Moehler TM; Christiane H; Wagner-Gund B; Neben K; Kauczor HU; Goldschmidt H; Delorme S
Radiology; 2009 Aug; 252(2):477-85. PubMed ID: 19703885
[TBL] [Abstract][Full Text] [Related]
2. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
Dutoit JC; Vanderkerken MA; Verstraete KL
Eur J Radiol; 2013 Sep; 82(9):1444-52. PubMed ID: 23726124
[TBL] [Abstract][Full Text] [Related]
3. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates.
Stäbler A; Baur A; Bartl R; Munker R; Lamerz R; Reiser MF
AJR Am J Roentgenol; 1996 Oct; 167(4):1029-36. PubMed ID: 8819407
[TBL] [Abstract][Full Text] [Related]
4. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?
Spira D; Weisel K; Brodoefel H; Schulze M; Kaufmann S; Horger M
Acad Radiol; 2012 Jan; 19(1):89-94. PubMed ID: 22142681
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of whole-body CT and MRI versus projection radiography in the detection of osteolyses in patients with monoclonal plasma cell disease.
Wolf MB; Murray F; Kilk K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Eur J Radiol; 2014 Jul; 83(7):1222-1230. PubMed ID: 24793843
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparison of conventional radiography, low-dose computed tomography and magnetic resonance imaging in monoclonal gammopathies.
Minarik J; Krhovska P; Hrbek J; Pika T; Bacovsky J; Herman M; Scudla V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Jun; 160(2):305-9. PubMed ID: 26740048
[TBL] [Abstract][Full Text] [Related]
7. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
Fechtner K; Hillengass J; Delorme S; Heiss C; Neben K; Goldschmidt H; Kauczor HU; Weber MA
Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease.
Moulopoulos LA; Varma DG; Dimopoulos MA; Leeds NE; Kim EE; Johnston DA; Alexanian R; Libshitz HI
Radiology; 1992 Dec; 185(3):833-40. PubMed ID: 1438772
[TBL] [Abstract][Full Text] [Related]
9. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
10. Fracture risk in monoclonal gammopathy of undetermined significance.
Melton LJ; Rajkumar SV; Khosla S; Achenbach SJ; Oberg AL; Kyle RA
J Bone Miner Res; 2004 Jan; 19(1):25-30. PubMed ID: 14753733
[TBL] [Abstract][Full Text] [Related]
11. [Contribution to the evaluation of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and in individual clinical stages of multiple myeloma].
Scudla V; Petrová P; Minarík J; Pika T; Budíková M; Bacovský J; Repovský S
Vnitr Lek; 2010 Jun; 56(6):591-601. PubMed ID: 20681472
[TBL] [Abstract][Full Text] [Related]
12. Patients with plasma cell disorders examined at whole-body dynamic contrast-enhanced MR imaging: initial experience.
Lin C; Luciani A; Belhadj K; Maison P; Vignaud A; Deux JF; Zerbib P; Pigneur F; Itti E; Kobeiter H; Haioun C; Rahmouni A
Radiology; 2009 Mar; 250(3):905-15. PubMed ID: 19244054
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
14. [Contribution of whole-body magnetic resonance in the diagnostics of monoclonal gammopathy of undetermined significance, multiple myeloma, and the assessment of Durie-Salmon Plus staging system].
Scudla V; Herman M; Minarík J; Pika T; Hrbek J; Bacovský J; Heinzová V
Vnitr Lek; 2011 Jan; 57(1):52-60. PubMed ID: 21351663
[TBL] [Abstract][Full Text] [Related]
15. Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow.
Lecouvet FE; Malghem J; Michaux L; Michaux JL; Lehmann F; Maldague BE; Jamart J; Ferrant A; Vande Berg BC
Radiology; 1997 Jul; 204(1):201-5. PubMed ID: 9205247
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and multiple myeloma].
Scudla V; Budíková M; Petrová P; Minarík J; Pika T; Bacovský J; Adamová D; Langová K;
Klin Onkol; 2010; 23(3):171-81. PubMed ID: 20608327
[TBL] [Abstract][Full Text] [Related]
17. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.
Lecouvet FE; Vande Berg BC; Michaux L; Malghem J; Maldague BE; Jamart J; Ferrant A; Michaux JL
Radiology; 1998 Dec; 209(3):653-60. PubMed ID: 9844655
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers of bone disease in asymptomatic early stage multiple myeloma. A study on their role in identifying high risk patients.
Corso A; Arcaini L; Mangiacavalli S; Astori C; Orlandi E; Lorenzi A; Passamonti F; Klersy C; Pascutto C; Canevari-Sciorati A; Lazzarino M
Haematologica; 2001 Apr; 86(4):394-8. PubMed ID: 11325645
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of the spine in plasma cell dyscrasias. A review.
Pertuiset E; Bellaiche L; Lioté F; Laredo JD
Rev Rhum Engl Ed; 1996 Dec; 63(11):837-45. PubMed ID: 9010972
[TBL] [Abstract][Full Text] [Related]
20. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]